Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors
Article in Translational Oncology (November 2023)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Translational Oncology (November 2023)
Article in Pharmaceutics (February 2023)
Article in Pharmaceuticals (January 2022)